Chronic Administration of COVID-19 Drugs Fluvoxamine and Lopinavir Shortens Action Potential Duration by Inhibiting the Human Ether-à-go-go-Related Gene and Cav1.2.

Zheng, Zequn; Cai, Dihui; Fu, Yin; Wang, Ying; Song, Yongfei; Lian, Jiangfang

Zheng, Zequn; Cai, Dihui; Fu, Yin; Wang, Ying; Song, Yongfei; Lian, Jiangfang.

Afiliación

Zheng Z; Department of Cardiovascular, Lihuili Hospital Facilitated to Ningbo University, Ningbo University, Ningbo, China.
Cai D; Ningbo Institute of Innovation for Combined Medicine and Engineering, Ningbo, China.
Fu Y; Department of Cardiovascular Medicine, First Affiliated Hospital of Shantou University Medical College, Shantou, China.
Wang Y; Department of Cardiovascular, Lihuili Hospital Facilitated to Ningbo University, Ningbo University, Ningbo, China.
Song Y; Ningbo Institute of Innovation for Combined Medicine and Engineering, Ningbo, China.
Lian J; Department of Cardiovascular, Lihuili Hospital Facilitated to Ningbo University, Ningbo University, Ningbo, China.

Front Pharmacol ; 13: 889713, 2022.

Article en En | MEDLINE | ID: mdl-35873575